CONVERGING ON ENGINEERED SOLUTIONS FOR REGENERATIVE MEDICINE
Medicine by Design harnesses the extraordinary expertise at the University of Toronto and its affiliated hospitals to undertake transformative research in regenerative medicine and cell therapy, power Toronto’s bioscience sector and strengthen Canada as a global leader in the field.
Events
Latest News
Researchers delay onset of amyotrophic lateral sclerosis (ALS) in laboratory models
A team of researchers led by scientists at the University of Toronto has delayed the onset of amyotrophic lateral sclerosis (ALS) in mice. They are cautiously optimistic that this research, which was funded in part by a Medicine by Design 2018 New Ideas Award, combined with other clinical advances, points to a potential treatment for ALS in humans.
Medicine by Design supports coronavirus research through contribution to Toronto COVID-19 Action Fund
Thirty-one research projects at U of T and its affiliated hospitals selected for funding to contribute to the global fight against the novel coronavirus.
Genome editing just got more versatile thanks to a new technology developed by Medicine by Design-funded investigators at U of T
Scientists can now edit multiple sites in the genome at the same time to learn how different DNA stretches co-operate in health and disease.
Opportunities
Learn more about our award programs, job openings, and learning and knowledge mobilization opportunities.
Medicine By Design By The Numbers
A Top Global Research University in the World's Most Diverse City
9 World-Class
Partner Hospitals, Including:
$114-million grant over seven years
Collaborative Team Projects Advancing 8 Disease Areas and Enabling Technologies
140+
Regenerative Medicine Researchers
300+
Graduate Students and Post-Doctoral Fellows
A Vibrant Life Sciences Ecosystem Located in Canada's Urban Innovation Hub
